山东步长制药股份有限公司关于控股股东股份质押的公告

Core Points - The controlling shareholder, Buchang (Hong Kong), holds 490,957,202 shares, accounting for 46.56% of the total share capital of the company [1] - A total of 100,930,000 shares have been pledged by Buchang (Hong Kong), representing 20.56% of its holdings and 9.57% of the company's total share capital [1] - Together with its concerted parties, Buchang (Hong Kong) holds 598,200,660 shares, which is 56.72% of the total share capital, with 100,930,000 shares pledged [1] - The pledged shares do not serve as collateral for major asset restructuring or performance compensation [2] - Buchang (Hong Kong) has sufficient risk control capabilities and repayment ability, with sources of repayment including operating income, operating profit, and investment income [3] - There is currently no risk of forced liquidation, and measures such as supplementary pledges or early repurchase of pledged shares will be taken if necessary [3] - The pledge will not lead to a change in actual control of the company or affect its operations and governance [4]